Intrathecal Pertuzumab and Trastuzumab in Patients With New Untreated Asymptomatic or Low Symptomatic Brain Metastasis in HER2 Positive Breast Cancer

Clinical trial NCT02598427 · TERMINATED

Trial details

NCT number

NCT02598427

Sponsor

Kimberly Blackwell

Status

TERMINATED

Phase

Phase 1

Study type

INTERVENTIONAL

Start date

2017-05-01

Primary completion

2018-02-22

Enrollment

1

View on ClinicalTrials.gov